I am delighted to announce the selection of Reynold A. Panettieri, Jr., MD, as the inaugural director of what will be a new RBHS Clinical and Translational Science Institute. Dr. Panettieri is a pulmonologist, immunologist, and translational researcher. His interests are in the cellular and molecular mechanisms that regulate airway smooth muscle cell growth and the immunobiology of airway smooth muscle. Dr. Panettieri's lab also focuses on cytosolic signaling pathways that mediate gene expression and alter myocyte function. In parallel with his basic science interests, Dr. Panettieri currently directs the comprehensive clinical program for the care of patients with asthma and is actively involved in clinical investigations focused on the management of asthma and COPD.
Dr. Panettieri, Robert L. Mayock, and David A. Cooper Professor of Pulmonary Medicine at the University of Pennsylvania, will lead all clinical and translational research initiatives across RBHS as he directs the creation and implementation of a division-wide Institute for Clinical and Translational Science (final name to be determined), reporting to my office.
His responsibilities will include developing and implementing a clinical and translational science infrastructure at RBHS and leading initiatives to expand independent clinical research funding, with a goal of achieving a coveted clinical and translational research award from the National Institutes of Health within five years and then leading the CTSA program as its PI.
Dr. Panettieri will also collaborate with the deans, department chairs, and faculty to conduct clinical and translational research across the schools, centers, institutes, and clinical care units of RBHS and encourage the formation of new translational research teams.
After earning his bachelor's degree from St. Joseph's University in 1975, Dr. Panettieri received his medical degree from the University of Pennsylvania, where he also continued for his internship and residency in medicine and fellowship in pulmonary diseases. Since 1995, Dr. Panettieri has been director of the comprehensive asthma program at the University of Pennsylvania Health System, where he also serves as chief of the asthma section for the Pulmonary, Allergy and Critical Care Division; director of the Airways Biology Initiative; associate program director for the General Clinical Research Center; director of the Integrative Health Sciences Facility Core, Center of Excellence in Environmental Toxicology, and deputy director of the center.
Dr. Panettieri is widely published with over 400 peer-reviewed articles and is currently the principal investigator or co-investigator of NIH and extramural grants totaling 12 million dollars. He holds editorial board positions for a number of publications, including the American Journal of Respiratory Cell and Molecular Biology, American Journal of Physiology and British Journal of Pharmacology. Among many honors, he is a member of the NIH Distinguished Editorial Panel and is a member of the American Society for Clinical Investigation and Association of American Physicians. He also received the Joseph R. Rodarte Award for Distinguished Achievement and Contributions in Respiratory Physiology and Medicine, Respiratory Structure and Function Assembly from the American Thoracic Society in 2013.
Dr. Panettieri is expected to join RBHS in the Fall.
Brian L. Strom, MD, MPH